Ophthalmology · Winston Salem, NC
NPI
1477557023
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1710 South Hawthorne Rd, Summit Eye Care
Winston Salem, NC, 27103
Phone (336) 765-0960
Groups this clinician bills Medicare through
Medicare paid, 2024
$358K
4,121 services
Medicare patients, 2024
857
Average age 76
Drug cost, 2024
$623K
7,052 prescriptions
Company payments, 2025
$829
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vickas Khemsara was code 99214 (office e&m - established), 689 times for 562 patients. In total Vickas Khemsara billed 4,121 services in 51 codes, and Medicare paid $358K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 689 | 562 | $84.02 | $58K |
| 92134 Computerized Ophthalmic Imaging | Office | 510 | 410 | $28.10 | $14K |
| 92136 Ultrasound - Nonspecific | Office | 350 | 151 | $17.93 | $6,274 |
| 99213 Office E&M - Established | Office | 277 | 207 | $64.40 | $18K |
| 92133 Computerized Ophthalmic Imaging | Office | 257 | 200 | $24.97 | $6,417 |
| 92083 Vision, Hearing, and Speech Services | Office | 189 | 172 | $44.58 | $8,425 |
| 64727 Musculoskeletal | Facility | 183 | 116 | $142.05 | $26K |
| 64708 Musculoskeletal | Facility | 182 | 116 | $242.59 | $44K |
| 99152 Anesthesia | Facility | 178 | 114 | $9.69 | $1,724 |
| 66984 Cataract Surgery | Facility | 169 | 116 | $354.83 | $60K |
| 92273 Test - Miscellaneous | Office | 152 | 117 | $89.07 | $14K |
| 83861 Clinical Chemistry | Office | 135 | 66 | $22.03 | $2,974 |
| 99204 Office E&M - New | Office | 131 | 131 | $111.81 | $15K |
| 66821 Cataract Surgery | Office | 95 | 64 | $237.76 | $23K |
| 92250 Angiography | Office | 94 | 87 | $26.96 | $2,534 |
By year: 2022 $460K for 5,064 services; 2023 $340K for 4,227 services; 2024 $358K for 4,121 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 135 | 66 | $22.03 | $2,974 |
Medicare prescription drug claims, 2024
In 2024, the drug Vickas Khemsara prescribed most often to Medicare patients was Latanoprost, with 1,691 prescriptions and refills. In total Vickas Khemsara wrote 7,052 Medicare prescriptions that cost $623K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,691 | 3,214 | 445 | $20K |
| Prednisolone Acetate Generic | 1,194 | 1,220 | 736 | $35K |
| Timolol Maleate Generic | 655 | 1,303 | 185 | $7,790 |
| Ciprofloxacin Hcl Generic | 590 | 593 | 519 | $5,712 |
| Ketorolac Tromethamine Generic | 580 | 609 | 515 | $12K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 455 | 910 | 125 | $5,734 |
| Brimonidine Tartrate Generic | 405 | 623 | 111 | $6,457 |
| Restasis Cyclosporine | 186 | 406 | 100 | $247K |
| Dorzolamide Hcl Generic | 184 | 308 | 51 | $3,455 |
| Lumigan Bimatoprost | 177 | 321 | 47 | $81K |
| Travoprost Generic | 132 | 226 | 35 | $23K |
| Combigan Brimonidine Tartrate/Timolol | 109 | 154 | 27 | $27K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 75 | 75 | 62 | $833 |
| Doxycycline Hyclate Generic | 64 | 81 | 37 | $2,498 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 64 | 99 | 21 | $11K |
Brand drugs: 2,841 claims; generic drugs: 4,211 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vickas Khemsara $829 ($829 in general payments such as food, travel and fees) from 7 companies. The largest payer was Alcon Vision LLC with $356.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.